Sudo Biosciences
Phase 1Sudo Biosciences develops first- and best-in-class medicines for serious neurological and immunological conditions like multiple sclerosis (MS) and other immune-mediated inflammatory conditions.
Founded
2020
Focus
Small Molecules
About
Sudo Biosciences develops first- and best-in-class medicines for serious neurological and immunological conditions like multiple sclerosis (MS) and other immune-mediated inflammatory conditions.
Funding History
2Total raised: $153M
Series B$116MTPGJan 15, 2024
Series A$37MCanaan PartnersJan 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile